CVS Group plc (LON:CVSG)
London · Delayed Price · Currency is GBP · Price in GBX 1,170.00
-18.00 (-1.52%)
Apr 9, 2026, 4:35 PM GMT
CVS Group Market Cap
CVS Group has a market cap or net worth of 833.46 million as of April 9, 2026. Its market cap has increased by 16.18% in one year.
Market Cap
833.46M
Enterprise Value
1.10B
Revenue
692.80M
Ranking
n/a
PE Ratio
51.88
Stock Price
1,170.00
Market Cap Chart
Since October 10, 2007, CVS Group's market cap has increased from 4.71M to 833.46M, an increase of 17,584.68%. That is a compound annual growth rate of 32.27%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 8, 2026 | 833.46M | -8.20% |
| Dec 31, 2025 | 907.93M | 50.66% |
| Dec 31, 2024 | 602.62M | -49.95% |
| Dec 29, 2023 | 1.20B | -12.67% |
| Dec 30, 2022 | 1.38B | -13.16% |
| Dec 31, 2021 | 1.59B | 49.49% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| AstraZeneca | 232.00B |
| GSK plc | 83.77B |
| Haleon | 32.93B |
| Smith & Nephew | 10.19B |
| Genus | 1.66B |
| Oxford Nanopore Technologies | 1.11B |
| Allergy Therapeutics | 683.91M |
| Oxford Biomedica | 664.95M |